CNMD
CONMED Corp
NYSE · Healthcare · Medical - Devices · US
$47.68
−3.19%Price chart
Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26
Key dataOct 26, 2026
Open$49.24
From 52W high−8.06%
Volume386573.00
Market cap$1.43B
P/E (TTM)25.7x
P/S (TTM)1.0x
Div yield—
Key dataOct 26, 2026
Open
$49.24
From 52W high
−8.06%
Volume
386573.00
Market cap
$1.43B
ValuationView details →
P/E (Fwd)
10.3x
EV/EBITDA
12.0x
P/E (TTM)
25.7x
RSI (14)
59.0
MomentumView details →
1D Return
−3.19%
YTD Return
+20.12%
SummaryUpdated Jun 1, 2026
CONMED Corporation (NYSE:CNMD) is a medical technology company founded in 1970 and headquartered in Largo, Florida. The company went public in 1987 and has grown to become a significant player in the surgical device industry, developing, manufacturing, and selling surgical equipment and related products for procedures worldwide. CONMED has built its business through both organic growth and strategic acquisitions, including notable purchases of In2Bones and Biorez in 2022, which expanded its orthopedic capabilities. The company operates globally, serving hospitals, surgery centers, and other healthcare institutions directly and through medical specialty distributors.
Similar companies
Latest newsMore news →
CONMED Corporation announced it will report its third quarter 2026 financial results after market close on October 28, 2026, with a conference call at 4:30 p.m. ET the same day.26d agoAvantor, Inc. appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026.36d ago